Pages that link to "Q28943510"
Jump to navigation
Jump to search
The following pages link to A genome-wide association identified the common genetic variants influence disease severity in beta0-thalassemia/hemoglobin E (Q28943510):
Displaying 50 items.
- beta thalassemia (Q3616632) (← links)
- hemoglobin E (Q17022356) (← links)
- BCL11A (Q18040602) (← links)
- Hb E/beta-thalassaemia: a common & clinically diverse disorder (Q24628973) (← links)
- Current and future alternative therapies for beta-thalassemia major (Q26750906) (← links)
- Customizing the genome as therapy for the β-hemoglobinopathies (Q26751061) (← links)
- Genomic approaches to identifying targets for treating β hemoglobinopathies (Q26799214) (← links)
- Fetal globin gene repressors as drug targets for molecular therapies to treat the β-globinopathies (Q26822810) (← links)
- Disease-associated mutations that alter the RNA structural ensemble (Q28475210) (← links)
- Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice (Q28551832) (← links)
- Global genetic architecture of an erythroid quantitative trait locus, HMIP-2 (Q28651652) (← links)
- Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies (Q30249259) (← links)
- Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin (Q33361527) (← links)
- Whole genome sequencing and imputation in isolated populations identify genetic associations with medically-relevant complex traits (Q33762970) (← links)
- Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA (Q33987569) (← links)
- Copy number variation in Thai population (Q34041126) (← links)
- Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients (Q34165031) (← links)
- Clinical severity of β-thalassaemia/Hb E disease is associated with differential activities of the calpain-calpastatin proteolytic system (Q34277778) (← links)
- Induction of fetal hemoglobin through enhanced translation efficiency of γ-globin mRNA (Q34398403) (← links)
- Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania (Q34456358) (← links)
- Genetic characterization of Greek population isolates reveals strong genetic drift at missense and trait-associated variants (Q34565337) (← links)
- Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians (Q34828414) (← links)
- Update on fetal hemoglobin gene regulation in hemoglobinopathies (Q34973945) (← links)
- A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression (Q35001653) (← links)
- Insight into the peopling of Mainland Southeast Asia from Thai population genetic structure (Q35041361) (← links)
- Structural and functional studies indicating altered redox properties of hemoglobin E: implications for production of bioactive nitric oxide (Q35067862) (← links)
- Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshot minisequencing approach (Q35087288) (← links)
- Sequence and analysis of a whole genome from Kuwaiti population subgroup of Persian ancestry (Q35108477) (← links)
- Haemoglobinopathies in southeast Asia. (Q35611077) (← links)
- Evolutionary context for the association of γ-globin, serum uric acid, and hypertension in African Americans (Q35873557) (← links)
- The potential of the riboSNitch in personalized medicine (Q35977505) (← links)
- The hemoglobin E thalassemias (Q36119387) (← links)
- Association of xmn I polymorphism and hemoglobin e haplotypes on postnatal gamma globin gene expression in homozygous hemoglobin e. (Q36282674) (← links)
- The switch from fetal to adult hemoglobin (Q36488272) (← links)
- Advances in understanding erythropoiesis: evolving perspectives (Q36803829) (← links)
- Non-transfusion-dependent thalassemias (Q36892558) (← links)
- Regulation of the fetal hemoglobin silencing factor BCL11A. (Q36909390) (← links)
- Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation (Q37088889) (← links)
- Minireview: Multiomic candidate biomarkers for clinical manifestations of sickle cell severity: Early steps to precision medicine (Q37107194) (← links)
- Network-based SNP meta-analysis identifies joint and disjoint genetic features across common human diseases (Q37195763) (← links)
- Transcriptional environment and chromatin architecture interplay dictates globin expression patterns of heterospecific hybrids derived from undifferentiated human embryonic stem cells or from their erythroid progeny (Q37333153) (← links)
- Fetal globin gene inducers: novel agents and new potential. (Q37552428) (← links)
- Comprehensive population-based genome sequencing provides insight into hematopoietic regulatory mechanisms (Q37598961) (← links)
- A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia (Q37674785) (← links)
- Lessons and Implications from Genome-Wide Association Studies (GWAS) Findings of Blood Cell Phenotypes (Q37689829) (← links)
- Advances in the understanding of haemoglobin switching (Q37702418) (← links)
- Modifier genes in Mendelian disorders: the example of hemoglobin disorders (Q37805602) (← links)
- HbE/β-Thalassemia: Basis of Marked Clinical Diversity (Q37809336) (← links)
- Optimal management of β thalassaemia intermedia. (Q37830724) (← links)
- Treatment strategies for hemoglobin E beta-thalassemia (Q38013168) (← links)